Compare Colgate-Palmolive Company (CL) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs Procter & Gamble Co — how do they compare? Colgate-Palmolive Company trades at $92.55 (market cap $74.26B), while Procter & Gamble Co trades at $144.83 (market cap $340.39B). The key difference: Procter & Gamble Co is far larger — about 4.6× Colgate-Palmolive Company's market cap, and Procter & Gamble Co pays the higher dividend (2.97%). Which is the better fit depends on your goals.
| CL | PG | |
|---|---|---|
Market Cap | $74.26B | $340.39B |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $99.14 | $167.18 |
52-Week Low | $74.98 | $138.10 |
Enterprise Value | $80.74B | $366.23B |
Dividend Yield | 2.28% | 2.97% |
Volume | — | 6,423,436 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.27, up 0.29% on the day, with a bullish technical signal and consistent earnings beats. The company reported Q2 2026 EPS of $0.99, exceeding estimates, driven by strong margins and organic growth in emerging markets, though North American performance remains weak. Operating cash flow remains robust at $4.2 billion in 2025, supporting shareholder returns.
Outlook is mixed: valuation appears stretched with a P/E of 36.72, but analyst consensus targets $99.10. Risks include competitive pressures in North America and high debt levels. The stock offers a stable dividend, but growth concerns and insider selling warrant caution.
Procter & Gamble (PG) trades at $144.77, down 0.69% on the day, with technical indicators showing a bearish trend despite recent earnings beats. The company maintains strong fundamentals with $84.28B revenue, 18.44% net margin, and consistent dividend payments, though valuation multiples remain elevated versus peers. Recent news highlights institutional positioning shifts and the company's new WNBA partnership.
PG offers stable cash flows and dividend growth potential but faces premium valuation concerns and modest revenue growth outlook. Near-term catalysts include Q3 2026 earnings, while risks include competitive pressures and economic sensitivity. Analyst consensus remains positive with a $161.20 price target suggesting 11% upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
